Surface Logix Inc. uses its expertise in biophysical
chemistry to create new small molecule drugs that are
optimized to meet the challenges of human physiology.
The company is advancing multiple internal programs
focused primarily on cardiovascular, metabolic,
inflammatory and fibrotic diseases.
|